Jesus G. Berdeja : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (51)
Les plus populaires
Liste
- Liste
- Tableau

1

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

Richardson, Paul G., Bensinger, William I., Huff, Carol Ann, Costello, Caitlin L., Lendvai, Nikoletta, Berdeja, Jesus G., Anderson, Larry D., Siegel, David S., Lebovic, Daniel, Jagannath, Sundar, Laub

Journal:

British Journal of Haematology

Année:

2018

Langue:

english

Fichier:

PDF, 180 KB

english, 2018

2

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial

Yee, Andrew J, Bensinger, William I, Supko, Jeffrey G, Voorhees, Peter M, Berdeja, Jesus G, Richardson, Paul G, Libby, Edward N, Wallace, Ellen E, Birrer, Nicole E, Burke, Jill N, Tamang, David L, Yan

Journal:

The Lancet Oncology

Année:

2016

Langue:

english

Fichier:

PDF, 390 KB

english, 2016

3

Open-Label Study to Determine the Feasibility of Ixazomib as Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma

Bachier, Carlos R., Shaughnessy, Paul J., Matous, Jeffrey, Berdeja, Jesus G.

Journal:

Biology of Blood and Marrow Transplantation

Année:

2018

Langue:

english

Fichier:

PDF, 196 KB

english, 2018

4

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

Kumar, Shaji K., Berdeja, Jesus G., Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob P., Hamadani, Mehdi, Stewart, A. Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan L., Berg,

Journal:

Année:

2019

Langue:

english

Fichier:

PDF, 1.07 MB

english, 2019

5

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Raje, Noopur, Berdeja, Jesus, Lin, Yi, Siegel, David, Jagannath, Sundar, Madduri, Deepu, Liedtke, Michaela, Rosenblatt, Jacalyn, Maus, Marcela V., Turka, Ashley, Lam, Lyh-Ping, Morgan, Richard A., Fri

Journal:

New England Journal of Medicine

Année:

2019

Langue:

english

Fichier:

PDF, 506 KB

english, 2019

6

Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia

Flinn, Ian W., Cherry, Mohamad A., Maris, Michael B., Matous, Jeffrey V., Berdeja, Jesus G., Patel, Manish

Journal:

American Journal of Hematology

Année:

2019

Langue:

english

Fichier:

PDF, 1.67 MB

english, 2019

7

Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma

Jesüs G. Berdeja, Richard J. Jones, Marianna L. Zahurak, Steven Piantadosi, Ross A. Abrams, Michael J. Borowitz, Georgia B. Vogelsang, Stephen J. Noga, Richard F. Ambinder, Ian W. Flinn

Journal:

Biology of Blood and Marrow Transplantation

Année:

2001

Langue:

english

Fichier:

PDF, 125 KB

english, 2001

8

5.30 Preliminary Results from a Phase I/II Study of Fludarabine (F), Rituximab (R), and Lenalidomide (L) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

Ian W. Flinn, Ines M. Macias-Perez, Patrick S. Tucker, R. Seth Cooper, Habib H. Doss, Dana S. Thompson, Jesus G. Berdeja, John D. Hainsworth

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2011

Langue:

english

Fichier:

PDF, 95 KB

english, 2011

9

Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia

Kelly, Kevin R., Shea, Thomas C., Goy, André, Berdeja, Jesus G., Reeder, Craig B., McDonagh, Kevin T., Zhou, Xiaofei, Danaee, Hadi, Liu, Hua, Ecsedy, Jeffrey A., Niu, Huifeng, Benaim, Ely, Padmanabhan

Journal:

Investigational New Drugs

Année:

2014

Langue:

english

Fichier:

PDF, 542 KB

english, 2014

10

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study

Kumar, Shaji K, Berdeja, Jesus G, Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob P, Hamadani, Mehdi, Stewart, A Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan L, Berg, Debor

Journal:

The Lancet Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 178 KB

english, 2014

11

Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study

Berdeja, Jesus, Jagannath, Sundar, Zonder, Jeffrey, Badros, Ashraf, Kaufman, Jonathan L., Manges, Robert, Gupta, Manish, Tendolkar, Amol, Lynch, Mark, Bleickardt, Eric, Paliwal, Prashni, Vij, Ravi

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2015

Langue:

english

Fichier:

PDF, 431 KB

english, 2015

12

Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial

Younes, Anas, Berdeja, Jesus G, Patel, Manish R, Flinn, Ian, Gerecitano, John F, Neelapu, Sattva S, Kelly, Kevin R, Copeland, Amanda R, Akins, Amy, Clancy, Myles S, Gong, Lucy, Wang, Jing, Ma, Anna, V

Journal:

The Lancet Oncology

Année:

2016

Langue:

english

Fichier:

PDF, 553 KB

english, 2016

13

Carfilzomib (CFZ, Kyprolis®), Lenalidomide (LEN, Revlimid®), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM)

Zimmerman, Todd M., Griffith, Kent, Jasielec, Jagoda K., Rosenbaum, Cara A., Berdeja, Jesus G., Vij, Ravi, Raje, Noopur, Reece, Donna E., Vesole, David H., Jagannath, Sundar, Kaminski, Mark, Cole, Cra

Journal:

Biology of Blood and Marrow Transplantation

Année:

2016

Langue:

english

Fichier:

PDF, 116 KB

english, 2016

14

Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder (HL-Like PTLD) Simulates Monomorphic B-Cell PTLD Both Clinically and Pathologically

Pitman, Sean D., Huang, Qin, Zuppan, Craig W., Rowsell, Edward H., Cao, Jeffrey D., Berdeja, Jesus G., Weiss, Lawrence M., Wang, Jun

Journal:

American Journal of Surgical Pathology

Année:

2006

Langue:

english

Fichier:

PDF, 477 KB

english, 2006

15

A Network Approach to Standardization of BMT Pathways

McSweeney, Peter A., Bachier, Carlos, Berdeja, Jesus G., Safah, Hana, Elayan, Mohammed M., LeMaistre, Charles F., Billups, Rocky, Cox, Tonya

Journal:

Biology of Blood and Marrow Transplantation

Année:

2015

Langue:

english

Fichier:

PDF, 51 KB

english, 2015

16

New approaches to blood and marrow transplantation for patients with low-grade lymphomas

Berdeja, Jesús G., Flinn, Ian W.

Journal:

Current Opinion in Oncology

Année:

2001

Langue:

english

Fichier:

PDF, 82 KB

english, 2001

17

TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia

Ghobrial, Irene M., Siegel, David S., Vij, Ravi, Berdeja, Jesus G., Richardson, Paul G., Neuwirth, Rachel, Patel, Chirag G., Zohren, Fabian, Wolf, Jeffrey L.

Journal:

American Journal of Hematology

Année:

2016

Langue:

english

Fichier:

PDF, 522 KB

english, 2016

18

A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis

Gupta, Neeraj, Hanley, Michael J., Harvey, R. Donald, Badros, Ashraf, Lipe, Brea, Kukreti, Vishal, Berdeja, Jesus, Yang, Huyuan, Hui, Ai-Min, Qian, Mark, Zhang, Xiaoquan, Venkatakrishnan, Karthik, Cha

Journal:

British Journal of Haematology

Année:

2016

Langue:

english

Fichier:

PDF, 235 KB

english, 2016

19

Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes

Garcia-Manero, Guillermo, Montalban-Bravo, Guillermo, Berdeja, Jesus G., Abaza, Yasmin, Jabbour, Elias, Essell, James, Lyons, Roger M., Ravandi, Farhad, Maris, Michael, Heller, Brian, DeZern, Amy E.,

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 267 KB

english, 2017

20

Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy

Berdeja, Jesus G., Bauer, Todd, Arrowsmith, Edward, Essell, James, Murphy, Patrick, Reeves, James A., Boccia, Ralph V., Donnellan, William, Flinn, Ian

Journal:

British Journal of Haematology

Année:

2017

Langue:

english

Fichier:

PDF, 405 KB

english, 2017

21

A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia

Donnellan, William, Berdeja, Jesus G., Shipley, Diana, Arrowsmith, Edward R., Wright, David, Lunin, Scott, Brown, Richard, Essell, James H., Flinn, Ian W.

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 304 KB

english, 2017

22

Efficacy and Safety of Once-Weekly Carfilzomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma: Secondary Analysis from the CHAMPION-1 Study by Prior Lines of Therapy

Berdeja, Jesus, Rifkin, Robert, Lyons, Roger, Cartmell, Alan, Coleman, Morton, Yang, Hui, Zahlten-Kumeli, Anita, Iskander, Karim, Berenson, James

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2017

Langue:

english

Fichier:

PDF, 84 KB

english, 2017

23

Single-Arm, Phase 2 Study of Elotuzumab in Combination With Pomalidomide and Dexamethasone in Patients With Multiple Myeloma Who Are Relapsed/Refractory to Lenalidomide: Initial Safety Data

Jagannath, Sundar, Berdeja, Jesus, Rifkin, Robert, Cole, Craig, Thompson, Michael A., Ricafort, Rosanna J., Scofield, Amanda, Mohamed, Hesham, Sy, Oumar, Vij, Ravi, Bensinger, William

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2017

Langue:

english

Fichier:

PDF, 64 KB

english, 2017

24

Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187)

Rifkin, Robert, Davies, Faith, Palumbo, Antonio, Zonder, Jeffrey A., Girnius, Saulius, Costello, Caitlin, Usmani, Saad, Berdeja, Jesus, Omel, Jim, Thompson, Michael, Schwartz, J Sanford, Hajek, Roman,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2017

Langue:

english

Fichier:

PDF, 72 KB

english, 2017

25

Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT)

Kumar, Shaji, Berdeja, Jesus, Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob, Hamadani, Mehdi, Stewart, A. Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan, Berg, Deborah, Lia

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2017

Langue:

english

Fichier:

PDF, 82 KB

english, 2017

26

Single-Arm, Phase 2 Study of Elotuzumab in Combination With Pomalidomide and Dexamethasone in Patients With Multiple Myeloma Who Are Relapsed/Refractory to Lenalidomide: Initial Safety Data

Jagannath, Sundar, Berdeja, Jesus, Rifkin, Robert, Cole, Craig, Thompson, Michael A., Ricafort, Rosanna J., Scofield, Amanda, Mohamed, Hesham, Sy, Oumar, Vij, Ravi, Bensinger, William

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2017

Langue:

english

Fichier:

PDF, 87 KB

english, 2017

27

Twice-weekly Ixazomib plus Lenalidomide-dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-term Follow-up Data for Patients Not Undergoing Stem Cell Transplantation (SCT)

Richardson, Paul, Hofmeister, Craig, Rosenbaum, Cara, Htut, Myo, Vesole, David, Berdeja, Jesus, Liedtke, Michaela, Chari, Ajai, Smith, Stephen, Lebovic, Daniel, Raje, Noopur, Liao, Eileen, Zhang, Xiao

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2017

Langue:

english

Fichier:

PDF, 71 KB

english, 2017

28

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma

Flinn, Ian W., Thompson, Dana S., Boccia, Ralph V., Miletello, Gerald, Lipman, Andrew, Flora, Douglas, Cuevas, Daniel, Papish, Steven W., Berdeja, Jesus G.

Journal:

British Journal of Haematology

Année:

2017

Langue:

english

Fichier:

PDF, 301 KB

english, 2017

29

Pevonedistat, a first-in-class NEDD8-activating enzyme (NAE) inhibitor, combined with azacitidine, in patients with AML

Swords, Ronan T., Coutre, Steven, Maris, Michael B., Zeidner, Joshua F., Foran, James M., Cruz, Jose, Erba, Harry P., Berdeja, Jesus G., Tam, Wayne, Vardhanabhuti, Saran, Pawlikowska-Dobler, Iwona, Fa

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 473 KB

english, 2018

30

Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial

Komrokji, Rami, Garcia-Manero, Guillermo, Ades, Lionel, Prebet, Thomas, Steensma, David P, Jurcic, Joseph G, Sekeres, Mikkael A, Berdeja, Jesus, Savona, Michael R, Beyne-Rauzy, Odile, Stamatoullas, As

Journal:

The Lancet Haematology

Année:

2018

Langue:

english

Fichier:

PDF, 327 KB

english, 2018

31

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Stein, Eytan M., Garcia-Manero, Guillermo, Rizzieri, David A., Tibes, Raoul, Berdeja, Jesus G., Savona, Michael R., Jongen-Lavrenic, Mojca, Altman, Jessica K., Thomson, Blythe, Blakemore, Stephen J.,

Journal:

Année:

2018

Langue:

english

Fichier:

PDF, 635 KB

english, 2018

32

Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma

Richardson, Paul G., Hofmeister, Craig C., Rosenbaum, Cara A., Htut, Myo, Vesole, David H., Berdeja, Jesus G., Liedtke, Michaela, Chari, Ajai, Smith, Stephen D., Lebovic, Daniel, Raje, Noopur, Byrne,

Journal:

British Journal of Haematology

Année:

2018

Langue:

english

Fichier:

PDF, 270 KB

english, 2018

33

Lorvotuzumab mertansine: antibody-drug-conjugate for CD56⁺ multiple myeloma

Journal:

Frontiers in Bioscience

Année:

2014

Langue:

english

Fichier:

PDF, 241 KB

english, 2014

34

A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study

Costello, Caitlin, Boccadoro, Mario, Usmani, Saad Z., Chari, Ajai, Rifkin, Robert M., Abonour, Rafat, Berdeja, Jesus, Cook, Gordon, Goldschmidt, Hartmut, Hajek, Roman, Hungria, Vania, Lee, Hans C., Le

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2018

Langue:

english

Fichier:

PDF, 87 KB

english, 2018

35

An Open-Label Phase 2 Study of Carfilzomib plus Dexamethasone to Assess Tolerability and Adherence in Patients with Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers

Fonseca, Rafael, Alsina, Melissa, Berdeja, Jesus, Heitner, Stephen B., Morris, Christopher, Khurana, Monica, Niesvizky, Ruben

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2018

Langue:

english

Fichier:

PDF, 93 KB

english, 2018

36

INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma

Costello, Caitlin, Davies, Faith E, Cook, Gordon, Vela-Ojeda, Jorge, Omel, Jim, Rifkin, Robert M, Berdeja, Jesus, Puig, Noemi, Usmani, Saad Z, Weisel, Katja, Zonder, Jeffrey A, Terpos, Evangelos, Spen

Journal:

Future Oncology

Année:

2019

Langue:

english

Fichier:

PDF, 1.68 MB

english, 2019

37

Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study

Biran, Noa, Siegel, David, Berdeja, Jesus G., Raje, Noopur, Cornell, R. Frank, Alsina, Melissa, Kovacsovics, Tibor, Fang, Belle, Kimball, Amy S., Landgren, Ola

Journal:

American Journal of Hematology

Année:

2019

Langue:

english

Fichier:

PDF, 814 KB

english, 2019

38

A Phase 1b/2 Study of Oprozomib in Patients With Advanced Multiple Myeloma and Waldenström Macroglobulinemia

Ghobrial, Irene M., Vij, Ravi, Siegel, David S., Badros, Ashraf Z, Kaufman, Jonathan L, Raje, Noopur S, Jakubowiak, Andrzej J., Savona, Michael R., Obreja, Mihaela, Berdeja, Jesus G

Journal:

Clinical Cancer Research

Année:

2019

Langue:

english

Fichier:

PDF, 1.41 MB

english, 2019

39

Oprozomib, pomalidomide, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Shah, Jatin, Usmani, Saad, Stadtmauer, Edward A., Rifkin, Robert M., Berenson, James R., Berdeja, Jesus G., Lyons, Roger M., Klippel, Zandra, Chang, Yu-Lin, Niesvizky, Ruben

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2019

Langue:

english

Fichier:

PDF, 1.79 MB

english, 2019

40

A Phase 1b/2 Study of Oprozomib in Patients With Advanced Multiple Myeloma and Waldenström Macroglobulinemia

Ghobrial, Irene M., Vij, Ravi, Siegel, David S., Badros, Ashraf Z, Kaufman, Jonathan L, Raje, Noopur S, Jakubowiak, Andrzej J., Savona, Michael R., Obreja, Mihaela, Berdeja, Jesus G

Journal:

Clinical Cancer Research

Année:

2019

Fichier:

PDF, 1.41 MB

2019

41

A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy

Weisel, Katja, Hungria, Vania, Leleu, Xavier, Lee, Hans, Rifkin, Robert, Costello, Caitlin, Abonour, Rafat, Chari, Ajai, Puig, Noemi, Berdeja, Jesus, Cook, Gordon, Thompson, Michael A., Boccadoro, Mar

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2019

Langue:

english

Fichier:

PDF, 90 KB

english, 2019

42

A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)

Alsina, Melissa, Landgren, C. Ola, Raje, Noopur, Niesvizky, Ruben, Bensinger, William I., Berdeja, Jesus, Kovacsovics, Tibor, Vesole, David, Fang, Belle, Kimball, Amy, Siegel, David S.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2019

Fichier:

PDF, 66 KB

2019

43

Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients

Reece, Donna, Bahlis, Nizar J., Samaras, Christy Joy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mirelis

Journal:

Clinical Lymphoma Myeloma and Leukemia

Année:

2019

Fichier:

PDF, 85 KB

2019

44

First-in-Human Phase 1 Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients With Relapsed and Refractory Multiple Myeloma

Vij, Ravi, Nath, Rajneesh, Afar, Daniel E.H., Mateos, Maria Victoria, Berdeja, Jesus G, Raab, Marc S, Guenther, Andreas, Martinez-Lopez, Joaquin, Jakubowiak, Andrzej J., Leleu, Xavier, Weisel, Katja,

Journal:

Clinical Cancer Research

Année:

2020

Langue:

english

Fichier:

PDF, 2.29 MB

english, 2020

45

Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

Gavriatopoulou, Maria, Chari, Ajai, Chen, Christine, Bahlis, Nizar, Vogl, Dan T., Jakubowiak, Andrzej, Dingli, David, Cornell, Robert F., Hofmeister, Craig C., Siegel, David, Berdeja, Jesus G., Reece,

Journal:

Année:

2020

Langue:

english

Fichier:

PDF, 1.37 MB

english, 2020

46

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma

Rowinsky, Eric K., Paner, Agne, Berdeja, Jesus G., Paba-Prada, Claudia, Venugopal, Parameswaran, Porkka, Kimmo, Gullbo, Joachim, Linder, Stig, Loskog, Angelica, Richardson, Paul G., Landgren, Ola

Journal:

Investigational New Drugs

Année:

2020

Fichier:

PDF, 261 KB

2020

47

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

Siegel, David S., Schiller, Gary J., Samaras, Christy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mireli

Journal:

Année:

2020

Fichier:

PDF, 665 KB

2020

48

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of multiple myeloma

Shah, Nina, Aiello, Jack, Avigan, David E, Berdeja, Jesus G, Borrello, Ivan M, Chari, Ajai, Cohen, Adam D, Ganapathi, Karthik, Gray, Lissa, Green, Damian, Krishnan, Amrita, Lin, Yi, Manasanch, Elisabe

Journal:

Journal for ImmunoTherapy of Cancer

Année:

2020

Fichier:

PDF, 554 KB

2020

49

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Jasielec, Jagoda, Kubicki, Tadeusz, Raje, Noopur, Vij, Ravi, Reece, Donna, Berdeja, Jesus G, Derman, Benjamin, Rosenbaum, Cara A, Richardson, Paul G, Gurbuxani, Sandeep, Major, Sarah, Wolfe, Brittany,

Journal:

Année:

2020

Fichier:

PDF, 2.42 MB

2020

50

Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma

Dhakal, Binod, DâSouza, Anita, Callander, Natalie, Chhabra, Saurabh, Fraser, Raphael, Davila, Omar, Anderson, Kenneth, Assal, Amer, Badawy, Sherif M., Berdeja, Jesus, Cerny, Jan, Comenzo, Raymond, C

Journal:

British Journal of Haematology

Année:

2020

Fichier:

PDF, 643 KB

2020